Related Experiment Video
Updated: Jan 14, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Hypomagnesaemia-associated hypokalaemia requires activation of both ENaC and ROMK
Yujiro Maeoka1,2, Xin-Peng Duan3, Cheng-Biao Zhang3
1Department of Medicine, Division of Nephrology & Hypertension, Oregon Health & Science University, Portland, Oregon, USA.
Abstract:
Hypokalaemia is common in hypomagnesaemic patients, but the in vivo mechanisms have not been determined. Along the distal nephron, lower intracellular Mg2+ has been proposed to release the Mg2+-mediated inhibition of renal outer medullary K+ (ROMK) channels, increasing urinary K+ excretion. Higher activity of the epithelial Na+ channel (ENaC), which provides the driving force for K+ secretion via ROMK, may also be required. We tested the hypothesis that hypomagnesaemia-induced hypokalaemia is associated with higher activities of both ENaC and ROMK. C57BL/6J mice were fed normal (NL), low Mg2+ (LM), low Na+ (LS) or low Na+/Mg2+ (LS/LM) diets. Kidneys and blood were harvested for western blotting and measurement of plasma [K+]. ROMK activity was measured by patch-clamping of split-open distal convoluted tubule 2 (DCT2)/connecting tubule (CNT) from mice on NL or LS/LM diets. Plasma [K+] was significantly lower in mice on LS/LM diet. Compared with mice on NL diet, abundances of cleaved α- and γ-ENaC, which correlate with ENaC activity, were higher in mice on LS diet, and lower in mice on LM diet but not on LS/LM diet, suggesting Na+ and Mg2+ restriction counteract each other. A lower natriuretic response to acute amiloride administration confirmed lower ENaC activity in mice on LM diet. ROMK activity along DCT2/CNT was higher in mice on LS/LM but not on LM diet compared with mice on NL diet. Together, our data suggest that Mg2+ restriction inhibits ENaC activity, and both higher ENaC activity and disinhibition of ROMK are required for the development of hypokalaemia in the context of hypomagnesaemia. KEY POINTS: In patch-clamping experiments, lower intracellular Mg2+ releases the Mg2+-mediated inhibition of renal outer medullary K+ (ROMK) channels, increasing urinary K+ excretion, but hypomagnesaemia does not always lead to hypokalaemia in several genetic disorders and animal experiments. Epithelial sodium channel (ENaC)-mediated Na+ entry provides the driving force for K+ secretion via ROMK, but how hypomagnesaemia affects ENaC activity remains unknown. We found that ENaC activity is lower following dietary Mg2+ restriction but is preserved with combined Mg2+/Na+ restriction, stimulating K+ secretion via ROMK. Our findings probably explain why Mg2+ restriction alone cannot cause hypokalaemia in vivo and provide new insights into the mechanisms of hypomagnesaemia-induced hypokalaemia.
More Related Videos
08:56Demonstration of Proteolytic Activation of the Epithelial Sodium Channel ENaC by Combining Current Measurements with Detection of Cleavage Fragments
Published on: July 5, 2014
11:08Double-barreled and Concentric Microelectrodes for Measurement of Extracellular Ion Signals in Brain Tissue
Published on: September 5, 2015
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Skeleton and Calcium Homeostasis
Antihypertensive Drugs: Potassium-Sparing Diuretics
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...